Clarivate Plc, a global leader in transformative intelligence, has announced the launch of DRG Fusion, an innovative analytics platform designed to support commercial operations in the life sciences sector. Leveraging integrated real-world data and the expertise of clinical and data science professionals, DRG Fusion simplifies data management and delivers actionable insights to biopharma and medtech organizations.
In today’s rapidly evolving healthcare landscape, biopharma and medtech companies are grappling with fragmented data sources, increasing competition, and shifting market dynamics. DRG Fusion addresses these challenges by providing integrated medical and pharmacy claims data, along with other real-world sources, to help organizations better understand disease and competitive landscapes. The platform empowers users to enhance patient acquisition and retention strategies, improving overall market performance.
Key Features of DRG Fusion
• Integrated Real-World Data: Combines medical and pharmacy claims with other relevant sources to create a unified view of the market.
• Pre-Built Modules: Configurable dashboards tailored for patient journey analysis, market access optimization, patient segmentation, and commercial targeting.
• User-Friendly Design: Streamlines workflows with ready-made visuals and tables, making it easier for teams to identify gaps and opportunities.
• Ongoing Data Refreshes: Ensures up-to-date insights, enabling organizations to adapt quickly to changing market conditions.
DRG Fusion is designed for commercial, sales, and marketing teams, providing a modular approach that aligns with specific functional needs. With its intuitive interface and powerful analytics, the platform accelerates decision-making, helping organizations drive patient-focused outcomes and improve market positioning.
Clarivate’s launch of DRG Fusion underscores its commitment to empowering life sciences organizations with transformative tools to create a healthier future.
Click here to read the original press release.
